Eiger BioPharmaceuticals, Inc. (EIGR) Social Stream



Eiger BioPharmaceuticals, Inc. (EIGR): $1.73

0.18 (-9.21%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add EIGR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#168 of 370

in industry

EIGER BIOPHARMACEUTICALS INC (EIGR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering EIGER BIOPHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 4 $49 $21 $31.25 $0.23 13486.96%
2022-03-11 4 $28 $21 $25.333 $0.23 10914.35%
2022-08-05 3 $29 $22 $26 $0.23 11204.35%
2022-08-07 3 $29 $21 $25.666 $0.23 11059.13%
2022-11-04 3 $48 $21 $32.333 $0.23 13957.83%
2022-11-14 3 $48 $20 $32 $0.23 13813.04%
2022-12-09 3 $48 $3 $20.6 $0.23 8856.52%
2022-12-13 3 $20 $3 $9.2 $0.23 3900%
2023-05-12 3 $9 $3 $5.5 $0.23 2291.3%
2023-08-16 3 $9 $1 $4.75 $0.23 1965.22%
2023-11-13 4 $5 $1 $3 $0.23 1204.35%

The Trend in the Analyst Price Target


EIGR's average price target has moved down $21.5 over the prior 19 months.

EIGR reports an average of 692.98% for its upside potential over the past 34 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-06-30 3 9 1 4.75 0.704 574.72%
2023-08-16 4 9 1 4.75 0.700 578.57%
2023-08-16 3 9 1 4.75 0.700 578.57%
2023-08-29 4 9 1 4.50 0.848 430.66%
2023-11-13 4 9 1 4.50 0.303 1385.15%

EIGR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 52 weeks, EIGR's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how EIGER BIOPHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1790.33% of that group.
  • In terms of how EIGER BIOPHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 153.64% of that group.
  • In terms of how EIGER BIOPHARMACEUTICALS INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -1075.17% of that group.
  • In the context of stocks in the small market cap category, EIGER BIOPHARMACEUTICALS INC's average analyst price target is higher than 786.63% of them.

Stocks similar to EIGER BIOPHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OCGN, ADVM, and CGEN.

Make investment decisions regarding EIGR using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!